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.2012.06.0Abstract We studied the effect of gold nanoparticles (NPs) on oxidative stress markers including
reduced glutathione (GSH) and malondialdehyde (MDA) in different organs of rats. Adult male
Wistar-Kyoto rats were randomly divided into 3 groups of 5 animals each. One group served as
control and received vehicle only. The remaining two groups were treated with 50 ll of 10 nm sized
gold NPs, daily for 3 and 7 days, respectively. The rats were sacriﬁced 24 h after the last injection of
NPs. Administration of gold NPs did not cause any signiﬁcant change in GSH levels in liver, lung
and heart on day 3 or day 7. There was no signiﬁcant effect of gold NPs on MDA levels in lung and
heart whereas signiﬁcant increases in MDA levels were found in the liver of rats treated with gold
nanoparticles on both 3 and 7 days post-dosing (ANOVA F= 7.113, P= 0.010). In conclusion,
the ﬁndings of this preliminary study suggest that gold NPs of 10 nm diameter produce signiﬁcant
lipid peroxidation in rat liver however lungs and heart do not show any oxidative stress. Further
studies are warranted to examine the effects of a broader dose range of gold NPs on the levels of
free radical indices in different organs of rats.
ª 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Although the biosafety of metallic gold is well recognized as
the toxicological behavior of gold nanoparticles is not clearlyepartment of Biochemistry,
niversity, Riyadh 11451, Saudi
oo.com, haseeb@ksu.edu.sa
Saud University.
g by Elsevier
y. Production and hosting by Else
05understood. The cytotoxicity of gold nanoparticles has been
studied in human cells and the results have shown that gold
nanoparticles are nontoxic up to 250 mM, while ionic gold
exhibits obvious cytotoxicity at 25 mM (Connor et al., 2005).
In general, most studies have excluded the toxicity of gold
nanoparticles (4–18 nm in diameter) (Connor et al., 2005;
Khan et al., 2007; Shukla et al., 2005) studying cell viability,
pro-apoptotic effects, oxidative stress and inﬂammatory
response. Brandenberger et al. (2010) concluded that non func-
tionalized gold particles with a size of 13–20 nm in diameter do
not cause acute adverse effects. In contrast, cytotoxic and
pro-apoptotic effects of gold particles 62 nm have been
reported (Pan et al., 2007; Tsoli et al., 2005), as well as the
impact of the charge of surface coatings on 2 nm particles onvier B.V. All rights reserved.
462 H.A. Khan et al.the reduction of cell viability (Goodman et al., 2004). This size
effect could be explained by an increased catalytic activity for
particles with less than 3–5 nm as described by Hvolbaek et al.
(2007) or by potential interaction with the DNA for particles
equal or smaller than 1.4 nm (Liu et al., 2003). Actually,
in vitro cultures cannot replicate the complexity of an
in vivo system or provide meaningful data about the response
of a physiologic system to an agent (Zhang et al., 2010).
There are few toxicologic reports of gold nanoparticles in
animal model, which is the preferred system for toxicologic
evaluation of a novel agent and should be used to characterize
the toxicity of gold nanoparticles. This investigation was there-
fore aimed to study the effect of gold nanoparticles (10 nm) on
oxidative stress markers including glutathione (GSH) and mal-
ondialdehyde (MDA) in different organs of rats.Table 1 Effect of gold NPs on GSH levels in different organs
of rats.
Treatment Liver Lung Heart
Control 976.78 ± 97.72 153.34 ± 35.81 681.89 ± 129.19
NP 3 days 1154.23 ± 191.68 260.22 ± 45.03 1093.43 ± 126.57
NP 7 days 830.39 ± 171.27 145.19 ± 23.07 897.90 ± 76.84
Values are means ± SEM, nmoles/g tissue.
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Figure 1 Percent change in the levels of GSH following the
exposure to gold NPs for 3 and 7 days.2. Materials and methods
2.1. Animals and treatment groups
Adult male Wistar-Kyoto rats, weighing 230 ± 20 g, were ob-
tained from the Laboratory Animal Centre. The animals were
housed in humidity- and temperature-controlled ventilated
cages on a 12 h day/night cycle, with free access to standard
laboratory rats’ diet and tap water. The animals were ran-
domly divided into 3 groups of 5 animals each. One group
served as control and received vehicle only. The remaining
two groups were treated with gold nanoparticles for 3 and
7 days, respectively.
2.2. Gold nanoparticles (NPs) and dosing
Gold nanoparticles of 10 nm (MKN-Au-010 of concentration
0.01%) were purchased from MK Impex Corp., Ontario,
Canada. GNPs demonstrate high electron density and are
highly homogeneous in shape and size. Doses of 50 ll of
10 nm NPs in aqueous solution were administered to animals
via intraperitoneal injection daily for 3 or 7 days. The rats were
sacriﬁced 24 h after the last injection of NPs. The specimens of
liver, lung and heart were collected for biochemical analyses.
All experiments were conducted in accordance with guidelines
approved by the Local Animal Care and Use Committee.
2.3. Analysis of glutathione (GSH)
The measurement of reduced glutathione (GSH) in different
organ tissues (liver, lung, heart) was performed according to
the procedure reported by Owen (1980). The tissue was homog-
enized in ice-cold perchloric acid (0.2 M) containing 0.01% of
ethylenediaminetetraacetic acid (EDTA). The homogenate was
centrifuged at 9,000g for 5 min, in a refrigerated centrifuge
(4 C). The enzymatic reaction was started by adding 100 ll
of clear supernatant in a spectrophotometric cuvette containing
800 ll of 0.3 mM reduced nicotinamide adenine dinucleotide
phosphate (NADPH), 100 ll of 6 mM 5,5-dithiobis-2-nitro-
benzoic acid (DTNB) and 10 ll of 50 units/ml glutathione
reductase (all these reagents were freshly prepared in a phos-
phate buffer at pH 7.5). The absorbance was measured over
a period of 120 s at 412 nm at 30 C. The GSH level was deter-
mined by comparing the rate of change of absorbance of the
test solution with that of standard GSH.2.4. Analysis of malondialdehyde (MDA)
The level of MDA in different organs of rats was analyzed
spectrophotometrically as described earlier (Utley et al.
1967). Tissues were weighed and homogenized (10% w/v) in
ice-cold 0.15 M potassium chloride in an ultraturax homoge-
nizer. Tissue homogenate (1 mL) was incubated at 37 C in a
metabolic shaker for 2 h. One milliliter of 10% (w/v) trichloro-
acetic acid was mixed with homogenate followed by centrifu-
gation at 3000 rpm for 10 min. Aliquots (1 mL) of the clear
supernatant were mixed with 1 mL of 0.67% (w/v) 2-thiobar-
bituric acid and placed in a boiling water bath for 10 min,
cooled and diluted with 1 mL distilled water. The absorbance
of the solution was recorded at 535 nm, and the concentration
of MDA was calculated using tetraethoxypropane as an exter-
nal standard.
3. Results
Administration of gold nanoparticles did not cause any signif-
icant change in GSH levels in liver (ANOVA F2,12 = 1.007,
P= 0.397), lung (ANOVA F2,12 = 3.306, P= 0.075) and
heart (ANOVA F2,12 = 3.245, P= 0.078) on day 3 or day 7
(Table 1). The levels of GSH slightly increased on day 3 fol-
lowing the exposure to gold nanoparticles and returned to near
normal levels on day 7 in liver, lung and heart. The percent
change in GSH as compared to control is shown in Fig. 1
for quick view.
There was no signiﬁcant effect of gold nanoparticles on
MDA levels in lung (ANOVA F2,12 = 0.262, P= 0.774) and
heart (ANOVA F2,12 = 0.867, P= 0.447). On the other hand,
signiﬁcant increases in MDA levels were found in the liver of
rats treated with gold nanoparticles on both 3 and 7 days
post-dosing (ANOVA F2,12 = 7.113, P= 0.010) (Table 2).
Table 2 Effect of gold NPs on MDA levels in different organs
of rats.
Treatment Liver Lung Heart
Control 0.186 ± 0.013 1.137 ± 0.149 0.628 ± 0.066
NP 3 days 0.286 ± 0.024* 1.152 ± 0.097 0.733 ± 0.061
NP 7 days 0.275 ± 0.017* 1.057 ± 0.105 0.706 ± 0.042
* P< 0.05 versus control group (Dunnett’s test). Values are
means ± SEM, nmoles/g tissue.
*
*
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Figure 2 Percent change in the levels of MDA following
exposure to gold NPs for 3 and 7 days. *P< 0.05 versus respective
control group using Dunnett’s test.
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in Fig. 2.
4. Discussion
The results of this study showed that intraperitoneal injection
of gold nanoparticles of 10 nm diameter do not cause any oxi-
dative stress in lung and heart of rats up to 1 week post dosing.
Recently, intraperitoneal injection of gold nanoparticles has
been investigated by Lasagna-Reeves et al. (2010) and the re-
sults showed a low level of toxicity at the dose range 320–
3200 lg/kg/day. Zhang et al. (2010) have noticed that gold
nanoparticles by intraperitoneal injection are less toxic than
oral administration at the dose of 1100 lg/kg (Zhang et al.,
2010). Nanoparticles size is a key factor in biological responses
to nanoparticles; smaller particles tend to be more toxic than
larger ones. Exposure of gold nanoparticles (average diameter
5.3 ± 1 nm) produced oxidative stress within 24 h in Mytilus
edulis (Tedesco et al., 2010). At sizes larger than 5 nm, the gen-
eral assumption is that gold is chemically inert like the bulk.
However, the chemical reactivity of gold particles for diame-
ters less than 3 nm is most likely different than larger gold
nanoparticles (Tsoli et al., 2005).
Exposure of three gold nanoparticle reference materials (10,
30 and 60 nm), as recommended by the National Institute of
Standards and Technology Nelson, did not result any free rad-
icals generation as measured by electron paramagnetic reso-
nance spectroscopy (Nelson et al., 2011). Modiﬁed gold
nanoparticles (10 nm size) have been shown to dismutate
superoxide radicals (Cao et al., 2011). The gold coating sup-
ported on diamond nanoparticles exhibits about a twofold
higher antioxidant activity than glutathione, one of the refer-ence antioxidant systems (Martı´n et al., 2010). Gold nanopar-
ticles have also attenuated lipopolysaccharide-induced nitric
oxide production by inhibiting proinﬂammatory cascade (Ma
et al., 2010). Zidki et al. (2000) have reported potential radical
scavenging property of gold nanoparticles against alkyl radi-
cals. Zhang et al. (2003) have also observed reduction in
EPR signal (indication of radical scavenging) following the
interaction of free radicals with 15 nm gold nanoparticles. Bar-
athmanikanth et al. (2010) have described the effectual role of
gold nanoparticles as an anti-oxidative agent, by inhibiting the
formation of reactive oxygen species, scavenging free radicals
and creating a sustained control over hyperglycemic conditions
suggesting the potential of gold nanoparticles as an economic
therapeutic remedy in diabetic complications. Recently, the
protective effect of 13 and 50 nm gold NPs on joint swelling
in a rat arthritis model has been attributed to increased level
of antioxidant enzyme catalase by gold NPs (Leonavicˇien _e
et al., 2012). Moreover, there is a plea for developing new arti-
ﬁcial antioxidant based on enhanced radical-scavenging activ-
ity by antioxidant-functionalized gold nanoparticles (Yin,
2007).
Our results showed signiﬁcant lipid peroxidation in liver of
rats treated with gold nanoparticles. The liver and spleen are
considered two dominant organs for biodistribution andmetab-
olism of gold nanoparticles (de Jong et al., 2008; Semmler-
Behnke et al., 2008; Chen et al., 2009; Balasubramanian et al.,
2010). It is thought that nanoparticles should have ﬁnal hydro-
dynamic diameters 65.5 nm to be excreted from the rat body
through kidneys (Choi et al., 2007). If gold nanoparticles are lar-
ger than this renal ﬁltration cutoff, they are not excreted in urine;
instead they are eliminated from the blood by the reticuloendo-
thelial system and thus tend to accumulate in the spleen and liver
(de Jong et al., 2008; vonMaltzahn et al., 2009). Aggregation of
nanoparticles could inﬂuence their ability to interact with or en-
ter cells, and thus adds complexity to the system. If the in situ
aggregation state of the nanoparticles is not considered, difﬁcul-
ties arise in the interpretation of data about nanoparticle biodis-
tribution or uptake (Alkilany and Murphy, 2010). The organ
distributions of gold nanoparticles are size-dependent while
small gold nanoparticles of 5–15 nm have wider organ distribu-
tion than that of large gold nanoparticles of 50–100 nm (de Jong
et al., 2008; Semmler-Behnke et al., 2008; Chen et al., 2009). It
has been found that gold nanoparticles with a long blood circu-
lation time can accumulate in the liver and spleen, and signiﬁ-
cantly affect the gene expression (Balasubramanian et al.,
2010; Cho et al., 2009). Thus the hepatotoxicity of gold nano-
particles may be attributed to accumulation of nanoparticles
in liver.
In conclusion, the ﬁndings of this preliminary study suggest
that gold nanoparticles of 10 nm diameter produce signiﬁcant
lipid peroxidation in liver however lungs and heart do not
show any oxidative stress. Further studies are warranted to
examine the effects of a broader dose range of gold nanopar-
ticles on the time course levels of free radical indices in differ-
ent organs of rats, for a more clear understanding of the
biosafety of gold nanoparticles.Acknowledgments
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